March 11-13, 2019

Cambridge Healthtech Institute’s 4th Annual Cancer Immunotherapy: Executive Summit

Stephen J. Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer
Presentation: “Voyager-V1: Systemic, Single-cycle, Trackable Oncolytic Virotherapy”